These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30847820)

  • 1. Validation of R-2-[
    Zhang Z; Liu S; Ma H; Nie D; Wen F; Zhao J; Sun A; Yuan G; Su S; Xiang X; Hu P; Tang G
    Mol Imaging Biol; 2019 Dec; 21(6):1127-1137. PubMed ID: 30847820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Imaging of Hepatocellular Carcinomas:
    Zhao J; Zhang Z; Nie D; Ma H; Yuan G; Su S; Liu S; Liu S; Tang G
    Mol Imaging; 2019; 18():1536012118821032. PubMed ID: 30799682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.
    Pillarsetty N; Punzalan B; Larson SM
    J Nucl Med; 2009 Oct; 50(10):1709-14. PubMed ID: 19759108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propionic Acid-Based PET Imaging of Prostate Cancer.
    Zhang Z; Liu S; Ma H; Xiang X; Nie D; Hu P; Tang G
    Mol Imaging Biol; 2021 Dec; 23(6):836-845. PubMed ID: 33876336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three ¹⁸F-labeled carboxylic acids with ¹⁸F-FDG of the differentiation tumor from inflammation in model mice.
    Wang H; Tang G; Hu K; Huang T; Liang X; Wu Z; Li S
    BMC Med Imaging; 2016 Jan; 16():2. PubMed ID: 26754531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
    Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
    Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [
    Sun P; Han Y; Zhu Y; Hu K; Huang S; Tan J; Wang M; Wu H; Tang G
    Nucl Med Biol; 2020; 88-89():1-9. PubMed ID: 32580089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Bioevaluation of Novel [
    Yang X; Wang F; Zhu H; Yang Z; Chu T
    Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
    Xu HL; Li M; Zhang RJ; Jiang HJ; Zhang MY; Li X; Wang YQ; Pan WB
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):140-148. PubMed ID: 29571649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
    Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
    J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Imaging of
    Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
    Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
    Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
    Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
    J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
    Takemoto K; Hatano E; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Matsumura K; Zaima M; Toriguchi K; Tanabe K; Kitamura K; Seo S; Taura K; Endo K; Uemoto S; Higashi T
    Ann Nucl Med; 2014 May; 28(4):371-80. PubMed ID: 24599824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of [
    Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S
    Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Potential and Biodistribution in vivo of 2-[18F]Fluoropropionic Acid in Breast Cancer-bearing Mice.
    Dang YH; Cai J; Li X; Wang L; Li F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Jun; 37(3):320-4. PubMed ID: 26149145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET.
    Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H
    J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.